Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by goldn1on Jan 07, 2020 11:56am
166 Views
Post# 30526268

RE:RE:Clarification!

RE:RE:Clarification!
coop: Everyone seems to have conspiracy theories when TLT management blows it. This "quarterly update" is another example of TLT fumbling the ball, again... They put out an NR in which you have to click on a separate link to decipher what in the update is material or not. I think this is a terrible way to keep investors informed and bring other investors in. I think it would be more prudent to issue NR's on the material information, if they want to have a quarterly report, that can be done separately. I only read it quick as it is difficult on my phone, (another reason the material information should be in the body of the NR), but I basically see more delays of the IND, 1 more patient treated and for some odd reason they left out the biggest part of the update which would be the results of P1 and possibly P2. The stock is down on decent volume, just like the awful financing, the blame falls squarely on management shoulders. I am sure the are just setting themselves up for more cheap warrants... smh, if it weren't for the doctors involved and the potential life changing technology, I would have flushed this management team a long time ago... we were due for an actual update, including P1 results, but that this cr@p... G1
Bullboard Posts